Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Safety and Efficacy Evaluation of the XERF Device for Aesthetic Treatments
Authors not listed
CynosureLutronic · 2025
Abstract
The goal of this clinical study is to evaluate the safety and clinical effectiveness of the XERF noninvasive dual-frequency monopolar radiofrequency device for aesthetic improvement of facial aging, including fine lines and wrinkles, eyebrow lifting, and tightening of lax tissue in the lower face, submental area, and neck in healthy adults.
Up to 60 participants may be enrolled across up to five clinical sites in the United States. Participants receive XERF treatments using 6.78 MHz and 2.0 MHz energy; most undergo two sessions approximately four weeks apart (the protocol allows up to three). Standardized photographs are taken at baseline and follow-up visits.
Outcomes are assessed approximately 30 and 90 days after the final treatment. Effectiveness is evaluated using investigator-assessed global aesthetic improvement and participant-reported satisfaction, while safety and tolerability are assessed through procedural pain ratings and monitoring of adverse events throughout the study.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-05 MST
Cite this
APA
Anonymous. (2025). Safety and Efficacy Evaluation of the XERF Device for Aesthetic Treatments. <em>CynosureLutronic</em>. https://clinicaltrials.gov/study/NCT07585591
Vancouver
Anonymous. Safety and Efficacy Evaluation of the XERF Device for Aesthetic Treatments. CynosureLutronic. 2025.
BibTeX
@misc{anon2025Safety,
title = {Safety and Efficacy Evaluation of the XERF Device for Aesthetic Treatments},
author = {Anonymous},
journal = {CynosureLutronic},
year = {2025},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
YOXLO B.V. 2026
Open access · US-GOV
An Open-Label, Single-Arm Study to Assess the Safety of Youniqor Consumption in Healthy Adults
Weinkle, Susan H., M.D. 2009
Open access · US-GOV
Safety and Efficacy of the Addition of 0.3% Lidocaine With EVOLENCE®
The Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College 2025
Open access · US-GOV
A Prospective, Randomized, and Split-Face Study to Evaluate the Efficacy and Safety of Focused Ultrasound for Facial Skin Laxity
Laboratoires Vivacy 2019
Open access · US-GOV
A Prospective, Monocentric, Uncontrolled Clinical Investigation to Evaluate the Efficacy and Safety of Stylage® XL Lidocaïne for the Restoration and/or Augmentation of Facial Volume
NIRA Innovations Inc. 2025
Open access · US-GOV
NIRA™ Laser M2.1 and Topical Treatment of Full-Face Wrinkles: A CLINICAL TRIAL
Promoitalia Group Spa 2026
Open access · US-GOV